NLS Pharmaceutics Ltd (NLSP)
0.155
+0.01
(+6.16%)
USD |
NASDAQ |
May 16, 16:00
0.155
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
AC Immune SA | -0.0674M |
CRISPR Therapeutics AG | 159.02M |
Addex Therapeutics Ltd | -0.0076M |
Molecular Partners AG | 49.71M |
MoonLake Immunotherapeutics | -73.64M |